Cardiac biomarkers | Placebo (n=11) | Drug (n=11) | p Value |
---|---|---|---|
Troponin T (ng/mL) | |||
Immediate pre-PCI | 0.03 (0.01, 0.13) | 0.04 (0.01, 0.28) | 0.44 |
8 hours | 0.07 (0.01, 0.15) | 0.045 (0.03, 0.16) | 0.67 |
16 hours | 0.14 (0.01, 0.18) | 0.06 (0.02, 0.45) | 0.84 |
% Change from immediate pre-PCI to 8 hours | 35 (0, 300) | 25 (−6, 68) | 0.34 |
% Change from immediate pre-PCI to 16 hours | 96 (0, 220) | 33 (0, 73) | 0.18 |
% Change from 8 to 16 hours | 0 (−7, 45) | 0 (−4, 3) | 0.47 |
CK-MB (ng/mL) | |||
Immediate pre-PCI | 2.8 (2, 3.9) | 5.5 (2.9, 10.5) | 0.11 |
8 hours | 3.8 (2.8, 9.1) | 4.8 (2.7, 7.7) | 0.91 |
16 hours | 11 (3.03, 16.18) | 4.4 (2.8, 8.7) | 0.23 |
% Change from immediate pre-PCI to 8 hours | 26 (−15, 134) | −17 (−26, −10) | 0.020* |
% Change from immediate pre-PCI to 16 hours | 107 (2, 446) | −17 (−38, 14) | 0.007* |
% Change from 8 to 16 hours | 27 (3, 82) | −3 (−18, 14) | 0.11 |
*p<0.05.
Data are expressed as median (IQR).
CK-MB, creatine kinase isoenzyme MB; PCI, percutaneous coronary intervention.